Markets:

Overview

News

Currencies

International

Treasuries

Omnicell, Inc. - Common Stock (NQ:OMCL)

50.39 -0.93 (-1.81%)

Streaming Delayed Price Updated: 3:46 PM EST, Jan 23, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

Headline News about Omnicell, Inc. - Common Stock

< Previous 1 2 3 4 5 6 Next >

3 Reasons to Sell OMCL and 1 Stock to Buy Instead

January 19, 2026

The past six months have been a windfall for Omnicell’s shareholders. The company’s stock price has jumped 80.2%, hitting $50.52 per share. This was partly thanks to its solid quarterly results, and...

Via StockStory

3 Small-Cap Stocks We Keep Off Our Radar

January 15, 2026

Investors looking for hidden gems should keep an eye on small-cap stocks because they’re frequently overlooked by Wall Street. Many opportunities exist in this part of the market, but it is also a...

Via StockStory

3 Inflated Stocks with Open Questions

January 11, 2026

The stocks featured in this article have all approached their 52-week highs. When these price levels hit, it typically signals strong business execution, positive market sentiment, or significant...

Via StockStory

Omnicell Executive Trims Holdings in $244,000 Sale as Stock Trades Near 2025 Highs ↗

January 05, 2026

The stock has rallied significantly from its 52-week low of $22.66 in May.

Via The Motley Fool

Topics Regulatory Compliance

Earnings Scheduled For October 30, 2025 ↗

October 30, 2025

Via Benzinga

Analyst Expectations For Omnicell's Future ↗

August 11, 2025

Via Benzinga

1 Cash-Producing Stock with Impressive Fundamentals and 2 We Avoid

December 24, 2025

A company that generates cash isn’t automatically a winner. Some businesses stockpile cash but fail to reinvest wisely, limiting their ability to expand.

Via StockStory

1 Healthcare Stock with Impressive Fundamentals and 2 We Brush Off

December 07, 2025

Personal health and wellness is one of the many secular tailwinds for healthcare companies. Players catalyzing medical advancements have benefited from elevated demand, which has supported the...

Via StockStory

Topics Stocks

Healthcare Technology for Providers Q3 Earnings: Privia Health (NASDAQ:PRVA) is the Best in the Biz

November 25, 2025

As the Q3 earnings season wraps, let’s dig into this quarter’s best and worst performers in the healthcare technology for providers industry, including Privia Health (NASDAQ:PRVA) and its peers.

Via StockStory

3 Low-Volatility Stocks That Concern Us

November 25, 2025

A stock with low volatility can be reassuring, but it doesn’t always mean strong long-term performance. Investors who prioritize stability may miss out on higher-reward opportunities elsewhere.

Via StockStory

CooperCompanies, iRhythm, Baxter, Omnicell, and Neogen Shares Skyrocket, What You Need To Know

November 21, 2025

A number of stocks jumped in the afternoon session after comments from a key Federal Reserve official bolstered hopes for an interest rate cut. New York Federal Reserve President John Williams stated...

Via StockStory

Topics Artificial Intelligence Economy Stocks

3 Russell 2000 Stocks with Warning Signs

November 06, 2025

Small-cap stocks in the Russell 2000 (^RUT) can be a goldmine for investors looking beyond the usual large-cap names. But with less stability and fewer resources than their bigger counterparts, these...

Via StockStory

Why Omnicell Stock Crushed the Market Today ↗

October 30, 2025

The company continues to benefit from demand for its next-generation healthcare tech offerings.

Via The Motley Fool

Why Omnicell (OMCL) Stock Is Trading Up Today

October 30, 2025

Shares of healthcare tech company Omnicell (NASDAQ:OMCL) jumped 10.9% in the morning session after the company reported strong third-quarter 2025 financial results that beat expectations and raised its...

Via StockStory

Topics Economy Government World Trade

Omnicell Inc (NASDAQ:OMCL) Surpasses Q3 2025 Estimates, Stock Rises on Strong Guidance ↗

October 30, 2025

Omnicell (OMCL) Q3 2025 earnings beat estimates, with revenue of $310.6M and non-GAAP EPS of $0.51. The stock rose 8% pre-market on the strong results and raised guidance.

Via Chartmill

Topics Earnings

Omnicell (NASDAQ:OMCL) Reports Bullish Q3, Stock Soars

October 30, 2025

Healthcare tech company Omnicell (NASDAQ:OMCL) reported Q3 CY2025 results beating Wall Street’s revenue expectations, with sales up 10% year on year to $310.6 million. On top of that, next quarter’s...

Via StockStory

Omnicell (OMCL) To Report Earnings Tomorrow: Here Is What To Expect

October 28, 2025

Healthcare tech company Omnicell (NASDAQ:OMCL) will be announcing earnings results this Thursday morning. Here’s what you need to know.

Via StockStory

Topics Artificial Intelligence

3 of Wall Street’s Favorite Stocks That Concern Us

October 27, 2025

Wall Street has set ambitious price targets for the stocks in this article. While this suggests attractive upside potential, it’s important to remain skeptical because analysts face institutional...

Via StockStory

Healthcare Technology Stocks Q2 Highlights: Tandem Diabetes (NASDAQ:TNDM)

October 26, 2025

Looking back on healthcare technology stocks’ Q2 earnings, we examine this quarter’s best and worst performers, including Tandem Diabetes (NASDAQ:TNDM) and its peers.

Via StockStory

Q2 Rundown: Privia Health (NASDAQ:PRVA) Vs Other Healthcare Technology for Providers Stocks

October 20, 2025

The end of the earnings season is always a good time to take a step back and see who shined (and who not so much). Let’s take a look at how healthcare technology for providers stocks fared in Q2,...

Via StockStory

Q2 Earnings Highs And Lows: Premier (NASDAQ:PINC) Vs The Rest Of The Healthcare Technology for Providers Stocks

October 14, 2025

As the Q2 earnings season wraps, let’s dig into this quarter’s best and worst performers in the healthcare technology for providers industry, including Premier (NASDAQ:PINC) and its peers.

Via StockStory

Topics Economy

Myriad Genetics, Omnicell, Globus Medical, Repligen, and Teleflex Stocks Trade Down, What You Need To Know

October 10, 2025

A number of stocks fell in the afternoon session after worries over worsening trade relations with China were triggered by critical comments from President Donald Trump.

Via StockStory

Topics Economy Government World Trade

1 Stock Under $50 with Promising Prospects and 2 Facing Challenges

October 02, 2025

Stocks trading between $10 and $50 can be particularly interesting as they frequently represent businesses that have survived their early challenges. However, investors should remain vigilant as some...

Via StockStory

3 Cash-Producing Stocks We Keep Off Our Radar

September 18, 2025

A company that generates cash isn’t automatically a winner. Some businesses stockpile cash but fail to reinvest wisely, limiting their ability to expand.

Via StockStory

3 Cash-Heavy Stocks We Approach with Caution

September 15, 2025

A cash-heavy balance sheet is often a sign of strength, but not always. Some companies avoid debt because they have weak business models, limited expansion opportunities, or inconsistent cash flow.

Via StockStory

3 Low-Volatility Stocks We Steer Clear Of

September 05, 2025

Low-volatility stocks may offer stability, but that often comes at the cost of slower growth and the upside potential of more dynamic companies.

Via StockStory

Topics Retirement

Q2 Earnings Highlights: Omnicell (NASDAQ:OMCL) Vs The Rest Of The Healthcare Technology for Providers Stocks

August 27, 2025

Looking back on healthcare technology for providers stocks’ Q2 earnings, we examine this quarter’s best and worst performers, including Omnicell (NASDAQ:OMCL) and its peers.

Via StockStory

2 Profitable Stocks Worth Investigating and 1 Facing Challenges

August 25, 2025

Not all profitable companies are built to last - some rely on outdated models or unsustainable advantages. Just because a business is in the green today doesn’t mean it will thrive tomorrow.

Via StockStory

OMCL Q2 Deep Dive: Product Innovation and Recurring Revenue Drive Upbeat Guidance

August 13, 2025

Healthcare tech company Omnicell (NASDAQ:OMCL) reported Q2 CY2025 results beating Wall Street’s revenue expectations, with sales up 5% year on year to $290.6 million. On top of that, next quarter’s...

Via StockStory

Topics World Trade

Bruker, Viatris, Sotera Health Company, Align Technology, and Omnicell Stocks Trade Up, What You Need To Know

August 12, 2025

A number of stocks jumped in the afternoon session after positive inflation data fueled hopes for an interest rate cut by the Federal Reserve. The latest Consumer Price Index (CPI) report showed...

Via StockStory

Topics Bonds Economy Stocks

< Previous 1 2 3 4 5 6 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.